Needham analyst Mike Matson reiterated a Buy rating on Masimo Corporation (NASDAQ:MASI) with a price target of $136.
On Thursday, the ITC upheld a January judge’s decision in an exclusion order, which found Apple Inc. (NASDAQ:AAPL) guilty of infringing Masimo’s patent rights. These rights pertain to a light-based technology used in blood-oxygen-level monitoring.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased